Posted by Michael Wonder on 12 Dec 2016
U.S. FDA approves Synjardy XR (empagliflozin/metformin hydrochloride extended-release) tablets for adults with type 2 diabetes
12 December 2016 - New once-a-day formulation indicated to improve blood sugar when used along with diet and exercise
The U.S. FDA has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes.
When used along with diet and exercise, Synjardy XR is indicated to improve blood sugar in adults with type 2 diabetes when both empagliflozin and metformin can be taken.
It is marketed by Boehringer Ingelheim and Eli Lilly.
